TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $865,000 | – | 49,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 206,800 | $36,314,000 | 8.27% |
| Fairmount Funds Management LLC | 886,281 | $15,563,000 | 5.66% |
| FRAZIER MANAGEMENT LLC | 3,123,107 | $54,984,000 | 4.40% |
| ACT CAPITAL MANAGEMENT, LLC | 466,000 | $8,183,000 | 4.24% |
| RAMIUS ADVISORS LLC | 338,042 | $5,936,000 | 3.54% |
| Western Standard LLC | 265,355 | $4,660,000 | 2.65% |
| HAVENS ADVISORS LLC | 109,000 | $1,914,000 | 2.30% |
| Crabel Capital Management, LLC | 423,490 | $7,436,000 | 2.29% |
| S. MUOIO & CO. LLC | 160,000 | $2,810,000 | 2.16% |
| Omni Partners US LLC | 2,366,824 | $41,561,000 | 2.13% |